Impact of intravenous fish oil on omega‐3 fatty acids and their derived lipid metabolites in patients with parenteral nutrition
Open Access
- 21 December 2022
- journal article
- research article
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 47 (2) , 287-300
Abstract
Background: Long‐term parenteral nutrition (PN) can lead to intestinal failure–associated liver disease (IFALD). Omega‐3 (n‐3) polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were shown to prevent IFALD. EPA‐derived and DHA‐derived oxylipins could contribute to this protective effect.Methods: We analyzed the effect of parenteral fish oil on oxylipins in patients with chronic intestinal failure receiving PN (n = 8). Patients first received no fish oil for 8 weeks and then switched to PN with 25% of fat as fish oil for another 8 weeks. Fatty acid profiles of red blood cells, PUFA‐derived oxylipins generated by cyclooxygenase, lipoxygenase (LOX), and cytochrome P450 (CYP) pathways, inflammatory markers, and liver function were assessed before and during fish‐oil PN.Results: EPA plus DHA in erythrocytes (the Omega‐3 Index) was high with a median of 11.96% at baseline and decreased to 9.57% without fish oil in PN. Addition of fish oil in PN increased the median Omega‐3‐Index to 12.75%. EPA‐derived and DHA‐derived CYP‐dependent and LOX‐dependent metabolites increased significantly with fish oil in PN, with less pronounced changes in arachidonic acid and its oxylipins. There were no significant changes of inflammation and liver function parameters.Conclusions: This study shows that fish oil–containing PN leads to primarily CYP‐ and LOX‐dependent n‐3 PUFA–derived inflammation‐dampening oxylipins arising from EPA and DHA. Within this short (16‐week) study, there were no significant changes in inflammation and clinical readout parameters.Keywords
This publication has 42 references indexed in Scilit:
- The Use of Fish Oil Lipid Emulsion in the Treatment of Intestinal Failure Associated Liver Disease (IFALD)Nutrients, 2012
- Red blood cell fatty acids are associated with depression in a case-control study of adolescentsProstaglandins, Leukotrienes and Essential Fatty Acids, 2012
- Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3 fatty acids is associated with increased omega-3 derived lipid mediators and reduced TNF-Carcinogenesis, 2011
- Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammationJournal of Clinical Investigation, 2011
- Arachidonic Acid-metabolizing Cytochrome P450 Enzymes Are Targets of ω-3 Fatty Acids*Journal of Biological Chemistry, 2010
- Parenteral Fish Oil as Monotherapy Improves Lipid Profiles in Children With Parenteral Nutrition–Associated Liver DiseaseJournal of Parenteral and Enteral Nutrition, 2010
- Parenteral Fish Oil Improves Outcomes in Patients With Parenteral Nutrition-Associated Liver InjuryAnnals of Surgery, 2009
- Omega‐3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines†‡Hepatology, 2007
- The contributions of aspirin and microbial oxygenase to the biosynthesis of anti-inflammatory resolvins: Novel oxygenase products from ω-3 polyunsaturated fatty acidsBiochemical and Biophysical Research Communications, 2005
- Indirect CalorimetryJournal of the American Dietetic Association, 1997